Stocks
Haoxi Health Technology LimitedHAO
NASDAQHealthcarePharmaceuticals$2.14
Price as of · delayed, not real-time
A micro-cap pharmaceutical company focused on developing and commercializing generic drugs for the Chinese market. Its pipeline targets chronic diseases and infectious conditions, with manufacturing and distribution concentrated in China. Investors track HAO for its exposure to China's generic drug sector and its low-float, high-volatility trading profile.
52W Range: $1.95-$4352.00
Congressional Interest in Haoxi Health Technology Limited (HAO)
No congressional trades have been disclosed for Haoxi Health Technology Limited (HAO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading HAO?
No congressional trades found for this stock.